Denmark· DK-28106271419

Optomease Vet.

A qn01ax92 product containing benzocain, registered in Denmark by Virbac S.A..

ATC QN01AX92

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedOptomease Vet.ATCQN01AX92REGISTER NO.DK-28106271419PACKS LISTED1CHECKEDSeptember 30, 2026

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
Benzocain
Manufacturer
Virbac S.A.
Country
Denmark (DK)
ATC code
QN01AX92
ATC class
QN01AX92
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28106271419

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under QN01AX92

Qn01ax92, as other registers publish it.

All benzocain products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3fae9b5f-024e-45a2-a7e0-ffe32d799019
GET /v1/drugs/3fae9b5f-024e-45a2-a7e0-ffe32d799019?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "koncentrat til opløsning til behandling af fisk",
  "source": "dkma",
  "strength": "200 mg/ml",
  "auth_role": "CMS",
  "dk_drugid": "28106271419",
  "substance": "Benzocain",
  "auth_procedure": "Decentral procedure",
  "in_medicinpriser": false,
  "registration_date_serial": "43937"
}

See everything about benzocain.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.